e-learning
resources
Stockholm 2007
Tuesday 18.09.2007
Novel genetic markers in pathology
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
3p microsatellite evaluation in NSCLC exhaled breath condensate: validation study
G. E. Carpagnano, A. Spanevello, C. Curci, M. G. Cagnazzo, M. P. Foschino Barbaro (Foggia, Italy)
Source:
Annual Congress 2007 - Novel genetic markers in pathology
Session:
Novel genetic markers in pathology
Session type:
Electronic Poster Discussion
Number:
3214
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
G. E. Carpagnano, A. Spanevello, C. Curci, M. G. Cagnazzo, M. P. Foschino Barbaro (Foggia, Italy). 3p microsatellite evaluation in NSCLC exhaled breath condensate: validation study. Eur Respir J 2007; 30: Suppl. 51, 3214
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Asbestosis
Whole genome sequencing of the highly virulent subtype B0/W148 of the Beijing genotype M.tuberculosis in Kharkiv, East Ukraine
Related content which might interest you:
Potentiality of detectionof microsatellite alterations in exhaled breath condensate of smokers as a tool for tumor susceptibility
Source: Eur Respir J 2005; 26: Suppl. 49, 327s
Year: 2005
Microsatellite alterations of 6p and 14p in the exhaled breath condensate of asthmatic subjects
Source: Annual Congress 2007 - Novel genetic markers in pathology
Year: 2007
Protein markers in the exhaled breath condensate of lung carcinoma patients
Source: Annual Congress 2012 - Exhaled biomarkers in airway diseases
Year: 2012
Early detection of lung cancer through analysis of VOC biomarkers in exhaled breath: The LuCID study.
Source: International Congress 2017 – Lung cancer: clinical research on exhaled breath, clinical trials in advanced NSCLC and real-life appraisals of immunotherapies
Year: 2017
Exhaled biomarkers in lung cancer
Source: Eur Respir J 2009; 34: 261-275
Year: 2009
The validation of assays used to measure biomarkers in exhaled breath condensate
Source: Eur Respir J 2008; 32: 1408-1409
Year: 2008
Lung disease diagnostic method based on proteomic analysis of exhaled breath condensate
Source: International Congress 2019 – Basic research of airway diseases
Year: 2019
Standardization of collection of exhaled breath condensate (EBC) for disease markers in use of different condensers
Source: Eur Respir J 2003; 22: Suppl. 45, 448s
Year: 2003
Reproducibility of exhaled breath condensate markers
Source: Eur Respir J 2008; 32:
Year: 2008
Attempt of detection of CYFRA 21-1 in exhaled breath condensate by patients with NSCLC
Source: Eur Respir J 2006; 28: Suppl. 50, 85s
Year: 2006
Metabolomic/proteomic analysis of biomarkers in exhaled breath condensates
Source: Annual Congress 2008 - PG8 - Cellular and molecular technologies of today - treatments of tomorrow
Year: 2008
Separate lung exhaled breath condensate collection confirms intrapulmonary origin of exhaled breath condensate acidification
Source: Eur Respir J 2007; 30: Suppl. 51, 364s
Year: 2007
HPV in exhaled breath condensate of lung cancer patients
Source: Annual Congress 2011 - Role of the biomarkers in airway diseases
Year: 2011
Detection and variability of cytokine-levels in exhaled breath condensate (EBC) of patients with stable COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 438s
Year: 2003
Exhaled breath condensate sample collection: standards and open issues
Source: Eur Respir Monogr 2010; 49: 152-161
Year: 2010
Detection of p53 mutation in exhaled breath condensate from patients with nonsmall cell lung cancer
Source: Eur Respir J 2002; 20: Suppl. 38, 14s
Year: 2002
Exhaled breath condensate is not suitable to detect EGFR somatic mutations
Source: Eur Respir J 2008; 32: 1123-1124
Year: 2008
Exhaled breath condensate biomarkers in COPD
Source: Eur Respir J 2008; 32: 472-486
Year: 2008
Diagnosis of lung diseases based on proteomic analysis of exhaled breath condensate
Source: International Congress 2017 – Clinical problems in lung diseases
Year: 2017
Inflammatory markers in exhaled breath condensate of two COPD phenotypes
Source: Eur Respir J 2005; 26: Suppl. 49, 260s
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept